Home
Issues
Aim & Scope
Open Access
Editorial Board
Indexing
Supporting Midwifery Associations
Contact us
Manuscript Types
Manuscript Formatting
How to submit
Special publications and Reprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CONFERENCE PROCEEDING
UBaP Study (Understanding Blood pressure changes after Pregnancy): The recovery of maternal hypertension in the postnatal period after a hypertensive pregnancy
1
City St George's- University of London, Cardiovascular and Genomics Research Institute, London, United Kingdom
2
St George's University NHS Hospitals, Fetal & Maternal Medicine, London, United Kingdom
3
University Hospital Dorset, Reproductive Health- Children and Non-Malignant Haematology, Dorset, United Kingdom
4
University Hospital Sussex, Maternity Research, Brighton, United Kingdom
5
Ashford and St. Peter's NHS Foundation Trust, Maternity Research, London, United Kingdom
6
Kingston University, Statistics, London, United Kingdom
7
Fatima College of Health Sciences, Midwifery, Abu Dhabi, United Arab Emirates
Eur J Midwifery 2026;10(Supplement 1):A1039
ABSTRACT
BACKGROUND:
Two out of three women who had a hypertensive disorder of pregnancy (HDP) will die from cardiovascular disease (CVD). The strongest risk factor for CVD is postpartum chronic hypertension, which can be prevented by targeted blood pressure (BP) therapy, health education and lifestyle changes. The postnatal period is the optimal time to influence such change, and midwives are provided with a unique opportunity to educate women about their future health.
OBJECTIVES:
To assess rate of and recovery from maternal hypertension following HDP and to identify factors which influence recovery.
METHODS:
Participants (n=128) underwent home as well as ambulatory blood pressure monitoring in the immediate 12 weeks postpartum and completed a questionnaire on their postpartum experience as a mother with hypertension.
RESULTS:
50% (n=64) of participants were hypertensive at 12 weeks postpartum. 48% (n=61) were considered to have elevated BP. Only 2% of women (n=3) recovered from their hypertension. 73% of those found to be hypertensive had discontinued their anti-hypertensive medication either self-directed or directed by their GP. Maternal age (OR 1.10, p=0.02), White ethnicity (OR 0.20, p=0.005), and a family history of hypertension (OR 3.22, p=0.01) were independent predictors of persistent postpartum hypertension.
CONCLUSIONS:
The cardiovascular consequences of HDP are not isolated to pregnancy. HDP should be considered a chronic medical condition that requires lifelong surveillance.
KEY MESSAGE:
Make every encounter count. Educate women on their future risk of CVD and associated co-morbidities. Poster session 4 (Group B)
Two out of three women who had a hypertensive disorder of pregnancy (HDP) will die from cardiovascular disease (CVD). The strongest risk factor for CVD is postpartum chronic hypertension, which can be prevented by targeted blood pressure (BP) therapy, health education and lifestyle changes. The postnatal period is the optimal time to influence such change, and midwives are provided with a unique opportunity to educate women about their future health.
OBJECTIVES:
To assess rate of and recovery from maternal hypertension following HDP and to identify factors which influence recovery.
METHODS:
Participants (n=128) underwent home as well as ambulatory blood pressure monitoring in the immediate 12 weeks postpartum and completed a questionnaire on their postpartum experience as a mother with hypertension.
RESULTS:
50% (n=64) of participants were hypertensive at 12 weeks postpartum. 48% (n=61) were considered to have elevated BP. Only 2% of women (n=3) recovered from their hypertension. 73% of those found to be hypertensive had discontinued their anti-hypertensive medication either self-directed or directed by their GP. Maternal age (OR 1.10, p=0.02), White ethnicity (OR 0.20, p=0.005), and a family history of hypertension (OR 3.22, p=0.01) were independent predictors of persistent postpartum hypertension.
CONCLUSIONS:
The cardiovascular consequences of HDP are not isolated to pregnancy. HDP should be considered a chronic medical condition that requires lifelong surveillance.
KEY MESSAGE:
Make every encounter count. Educate women on their future risk of CVD and associated co-morbidities. Poster session 4 (Group B)
| eISSN: | 2585-2906 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
